WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

R RESPIRATORY SYSTEM

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.


R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES

Theophyllines are classified in this group. Other respiratory stimulants are classified in R07AB - Respiratory stimulants.
Corticosteroids for systemic use, see H02.
Sympathomimetics for systemic treatment of rhinitis, see R01BA.

This group comprises mainly the xanthines. The DDDs for these substances are based on treatment of obstructive lung diseases.


R03DA Xanthines

A number of preparations containing e.g. theophylline are classified in this group even if they do not have asthma as an indication.
Combinations of xanthines and other agents (except adrenergics, see R03DB - Xanthines and adrenergics) are classified at separate 5th levels using the corresponding 50-series (e.g. mucolytics).

R03DB Xanthines and adrenergics

All combinations of xanthines and adrenergics are classified in this group.

R03DC Leukotriene receptor antagonists

Combinations with antihistamines (R06A) are classified in this group.

R03DX Other systemic drugs for obstructive airway diseases

This group comprises preparations, which cannot be classified in the preceding groups.
Interleukin inhibitors used in asthma are classified in this group.

Last updated: 2024-01-26